301 related articles for article (PubMed ID: 10817557)
1. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
3. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
Salvarani C; Hunder GG
Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis.
García-Martínez A; Hernández-Rodríguez J; Espígol-Frigolé G; Prieto-González S; Butjosa M; Segarra M; Lozano E; Cid MC
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):835-41. PubMed ID: 20535794
[TBL] [Abstract][Full Text] [Related]
5. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
7. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
9. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
[TBL] [Abstract][Full Text] [Related]
10. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
11. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
von Blotzeim SG; Borruat FX
Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
[TBL] [Abstract][Full Text] [Related]
12. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
[TBL] [Abstract][Full Text] [Related]
13. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
[TBL] [Abstract][Full Text] [Related]
14. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
[TBL] [Abstract][Full Text] [Related]
15. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Proven A; Gabriel SE; Orces C; O'Fallon WM; Hunder GG
Arthritis Rheum; 2003 Oct; 49(5):703-8. PubMed ID: 14558057
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
Salvarani C; Cantini F; Niccoli L; Catanoso MG; Macchioni P; Pulsatelli L; Padula A; Olivieri I; Boiardi L
J Rheumatol; 2003 Apr; 30(4):760-3. PubMed ID: 12672196
[TBL] [Abstract][Full Text] [Related]
19. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis.
Narváez J; Bernad B; Roig-Vilaseca D; García-Gómez C; Gómez-Vaquero C; Juanola X; Rodriguez-Moreno J; Nolla JM; Valverde J
Semin Arthritis Rheum; 2007 Aug; 37(1):13-9. PubMed ID: 17360027
[TBL] [Abstract][Full Text] [Related]
20. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]